Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m Pharmaceutical Technology
Finance, IT & News
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m Pharmaceutical Technology
Ukraine’s Defense Forces strike Russian radar, S-400 command-and-staff vehicle and supply depots Ukrinform
Seattle teachers' union, district talk negotiation breakdown as first day of school nears KOMO
AI layoffs shatter trust in corporate leadership hcamag.com
Kenya: Passengers stranded amid airport staff strike DW.com